SMGZY has been the topic of several other research reports. Zacks Investment Research raised Smiths Group from a hold rating to a buy rating and set a $27.00 price objective on the stock in a report on Thursday, January 25th. Barclays assumed coverage on Smiths Group in a report on Tuesday, February 13th. They set an overweight rating on the stock. Finally, Morgan Stanley raised Smiths Group from an underweight rating to an equal weight rating in a report on Wednesday, December 13th.
Smiths Group (SMGZY) opened at $21.45 on Friday. Smiths Group has a twelve month low of $19.14 and a twelve month high of $23.87. The company has a current ratio of 2.34, a quick ratio of 1.82 and a debt-to-equity ratio of 0.76.
Smiths Group Company Profile
Smiths Group plc is a technology company. The Company operates in five divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect and Flex-Tek. The John Crane division offers mechanical seals, seal support systems, engineered bearings and power transmission couplings, among others. The Smiths Medical division offers infusion systems, vascular access (including safety needles), patient airway and temperature management equipment, and specialty devices in areas of in vitro fertilization, diagnostics and emergency patient transport.
Receive News & Ratings for Smiths Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smiths Group and related companies with MarketBeat.com's FREE daily email newsletter.